Role of ER stress pathways References
Cancer UPR proteins are upregulated; protect tumor cells from hypoxia-induced apoptosis, cell surface PDI expression mediates tumor invasion [8, 90, 97, [113] [114] [115] Alzheimers disease Plaque formation and mutant presenilin-1 induces ER stress and neurodegeneration [59, 116, 117] Parkinsons disease Mutation of parkin results in ER stress/UPR and neurodegeneration [60, [118] [119] [120] Hutington's Disease Mutant huntingtin accumulation changes ER calcium homeostasis; results in UPR mediated neurodegeneration [121, 122] Amyotrophic lateral sclerosis Mutant SOD disrupts ERAD and activates ASK1 [123] Prion Disease Prion infection induces protective UPR pathways [58, 67, 124] Cerebral Ischemia UPR mediated CHOP activation and neuronal death [125] Viral Infection Infection induces UPR [126] Bipolar disease Current treatments induce UPR pathways, proposed role for XBP1 polymorphisms in predisposition [127, 128] Diabetes Impaired UPR pathways (PERK): Type 1; obesity induced ER stress and UPR mediated β-cell apoptosis: Type 2 [74, 75, 77, [129] [130] [131] Inflammation Mediated through UPR sensor, CREBH [132, 133] Atherosclerosis Oxidized lipids and homocysteins induce ER stress/UPR in vascular cells [78, 79, 82, [134] [135] [136] Autoimmune disease ER stress pathways and overloaded ER linked to autoantigen production [137, 138] Cardiovascular disease Myocardial infarction and/or cardiac schemia induces ER stress/ UPR protective pathways [84, 85, [139] [140] [141] Z-α1-antitrypsin deficiency Accumulation of mutant protein induces stress and early onset liver disease [142] 
Figure 1. Signal transduction pathways in ER stress-induced apoptosis. The aggregation of misfolded/unfolded proteins in the ER results in GRP78 dissociation and the sequential activation of the three ER stress receptors: pancreatic ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol-requiring enzyme 1 (IRE1). Activated PERK phosphorylates eukaryotic initiation factor 2α (eIF2α), which suppresses global mRNA translation and protein synthesis and activates ATF4 translation, which induces the transcription of genes aimed at restoring ER homeostasis. PERK phosphorylation of nuclear factor-E2-related factor 2 (Nrf2) regulates the expression of a number of genes involved in antioxidant defense pathways. Under chronic ER stress, activation of PERK induces the expression pro-apoptotic pathways involving ATF4-dependent CHOP expression. ATF6 is activated by proteolysis mediated by proteases after its translocation from the ER to the Golgi apparatus. Following proteolysis, active ATF6 translocates to the nucleus and regulates the expression of ER chaperones to facilitate protein folding, secretion, and degradation in the ER. Under severe ER stress ATF6 induces CHOP expression and mediates caspase activity. Activated IRE1 induces the expression of genes involved in ER-associated mRNA protein degradation and mediates the splicing of XBP1 mRNA. Spliced XBP1 translocates to the nucleus and controls the transcription induction of ER chaperones. If ER load is overwhelming IRE1 activates proapoptotic pathways through c-Jun NH 2 -terminal kinase (JNK) and nuclear factor-kappa-B (NF-κB). Apoptosis is additionally activated through IRE1 recruitment of TNF-receptor-associated factor 2 (TRAF2)
,
ER-stress mediated apoptosis
The UPR pathways outlined above define the early pro-survival response signals that are aimed at restoring ER homeostasis.
When the folding capacity is not restored all three UPR pathways contribute to cell apoptosis ( Figure 1 ). Recent studies suggest that the degree of ER stress and the differential stability of prosurvival and pro-death mRNAs/proteins may partially regulate cell fate [22] . Apoptosis is additionally activated through IRE1 recruitment of TNF-receptor-associated factor 2 (TRAF2) and apoptosissignal-regulating kinase 1 (ASK1), and through the activation of the mitogen-activated protein kinase (MAPK) signaling pathways of p38 and c-Jun NH 2 -terminal kinase (JNK). The importance of ASK1 in ER stress mediated apoptotic pathways is exemplified by either over-expression or knockout studies. In lung epithelial cells and mouse embryonic fibroblasts (MEFs), ASK1 over-expression induced apoptosis through mitochondria-dependent caspase-3 and -9 activation; while the neuronal cells of ASK1 -/-mice showed resistance to prolonged ER stress [24, 25] . IRE1 mediated TRAF2 recruitment also permits TRAF2 dissociation from procaspase-12 (pCP12), allowing for the activation of pCP12 and downstream caspases. JNK mediated phosphorylation of Bcl-2 and Bim induces apoptosis both by suppressing the anti-apoptotic activity of Bcl-2 and enhancing additional pro-apoptotic pathways [26] . Regulation through IRE1 association/dissociation with Jun activation domain binding protein 1 (JAB1) may play a role in determining the choice between the induction of cell survival or death responses [27] .
The complete in vivo signaling pathways involved in ER stressassociated apoptosis have not been entirely elucidated and are further confounded by research that suggests that cellular responses may be tissue, insult, and/or redox dependent [28] [29] [30] .
Protein Disulfide Isomerase
The ER lumen is a highly organized cellular compartment that contains numerous chaperones and oxidoreductases that assist in the activation of apoptotic pathways. The complexities underlying the molecular mechanisms that define this switch from pro-survival to pro-death response are evidenced by recent studies that reveal the roles of specific chaperone proteins as integration points in signaling pathways that determine cell fate [7] [8] [9] [10] [11] [12] . The following review discusses the dual role of PDI in cell death and survival during ER stress.
The UPR: where do we go from here?
In [15] . XBP-1s also induces the expression of the HSP40 family member p58 IPK , which binds to and inhibits PERK, resulting in a negative feedback loop and translational recovery [16] . p58 IPK induction may represent UPR success and the restoration to normal cellular functioning or alternatively allow for the synthesis of pro-apoptotic proteins.
Additional roles for IRE1 in translational attenuation and in mediating ER stress responses have been reported [17, 18] .
Following GRP78 dissociation, ATF6 activation involves redoxmediated regulated intra-membrane proteolysis (RIP) in the Golgi [19] . Proteolytic processing of ATF6 enables transcription factor binding and the regulation of a number of ER stress response genes, including the expression of ER chaperones, ERA components, and gene products with roles in lipid biogenesis and ER expansion [20, 21] .
Oxidative Protein Folding and the UPR
The oxidative environment of the ER is primed for the formation of disulfide bonds where glutathione (GSH) is the main redox buffer. PDI mediated folding of nascent proteins in the ER lumen involves repeated cycles of thiol oxidation and reduction;
processes which become up-regulated during ER stress.
During disulfide bond formation, PDI is reduced following the acceptance of electrons from cysteine residues ( Figure 2 ).
During this process PDI interacts with flavin adenine dinucleotide
(FAD) -dependent ER oxidoreductin (Ero1) enabling the passage of electrons to molecular oxygen and the restoration of oxidized PDI [41] . Inhibition of Ero1 activity results in the accumulation of PDI and the cessation of disulfide bond formation [42] . PDI also has molecular chaperone activity that can include non-Cys containing proteins [43] . In vivo, it is possible that this chaperone activity prevents nonspecific interactions. In an elegant study using the yeast UPR model system, Delic et al introduce the importance of inter-compartmental redox homeostasis between the ER and cytosol during the UPR and a role for cytosolic glutathione peroxidase in the oxidative protein folding pathway [44] . Under conditions of ER stress and activation of the UPR, the redox potential within ER environment becomes increasingly reduced [45] . PDI may provide a redox-dependent switch by acting as a chaperone rather than a disulfide isomerase in its reduced state. In vitro studies show that reduced PDI binds and in protein folding. Protein disulfide isomerases (PDI) compose a superfamily of more than 20 members reported to date that have diverse sequences and multiple functions including, acting as molecular chaperones, protein-binding partners, and hormone reservoirs [31, 32] . The highly abundant redox-active enzyme PDI (P4HB, PDIA1) was one of the initial ER chaperones to be reported and plays a crucial role in catalyzing disulfide bond formation, reduction, and isomerization. PDI may also act as an intracellular anti-inflammatory molecule through negative regulation of nuclear factor-kappa-B (NF-κB), inhibiting lipopolysaccharide (LPS)-induced pro-inflammatory cytokine production in macrophages [33] .
The majority of PDI family members are characterized by at least one thioredoxin (Trx)-like Cys-Xaa-Xaa-Cys catalytic domain responsible for regulating PDI redox activity and a KDEL-like ER retention signal sequence. While PDI is primarily an ER protein, PDI expression has been documented on the cell surface as well as in the mitochondria, nucleus, and cytosol [34] [35] [36] [37] . The ability to bypass KDEL-mediated ER anchoring has also been reported in the chaperone proteins GRP78 and GRP94, which can similarly display cell surface expression and extracellular secretion [38, 39] . Furthermore, ER stress can induce leakage of PDI into the cytoplasm [40] . The functional consequence of KDEL-containing PDI in non-ER compartments is poorly understood. 
Figure 2. The formation of disulphide bonds in the ER is driven by PDI and ERO1. During disulfide bond formation, ERO1 operates in association with the flavin, FAD. ERO1 uses a FAD-dependent reaction to transfer electrons from PDI to molecular oxygen (O 2 ), which results in the production of reactive oxygen species (ROS) in the from of H 2 O 2 and the oxidation of PDI. PDI is reduced following the acceptance of electrons from protein-folding substrates, thereby oxidizing thiol (SH) groups in the target protein's cysteine residues and forming disulphide bonds. Reduced GSH assists in disulphide-bond reduction, resulting in the production of oxidized glutathione (GSSG). Under conditions of ER stress and the UPR, GSH is consumed and the ER environment becomes increasingly reduced. Inhibition of Ero1 activity results in the accumulation of PDI

PDI: neuroprotective or proapoptotic?
ER stress-mediated PDI up-regulation in neurodegenerative diseases attenuates misfolded protein accumulation and prevents neurotoxicity. In neuronal cell models of Parkinson's disease and amyotrophic lateral sclerosis, PDI overexpression decreases synphilin-1 protein and mtSOD1, respectively [53, 68] .
The protective role for PDI in glial cells in response to brain ischemia has similarly been attributed to roles in decreasing protein misfolding [66] . It is worth noting however, that PDI does not decrease the number of inclusions formed by the variant of α1-antitrypsin linked with liver disease [69] . This suggests that PDI-mediated cellular protection may be disease and protein- emphasizing the importance of PDI subcellular localization in these pathways [70] .
PDIs can have similar anti-apoptotic/neuroprotective roles in transmissible neurodegenerative prion disorders. PDI overexpression protects against prion-induced neurotoxicity.
Furthermore, infected animals exhibit S-nitrosylation of PDI, while blocking cellular NOS inhibits PDI-SNO formation and associated cell cytoxicity [7] . Prion disease-induced ER stress unfolds cholera toxin in the ER lumen whereas PDI oxidation results in toxin release and cytosolic translocation [46, 47] It is broadly accepted that redox regulation through the reversible oxidation of susceptible cysteine residues influences the activity of proteins such as enzymes, transcription factors or transporters [50] [51] [52] . Given that PDI's active site cysteines are targets for redox defined post-translational modifications, such as S-glutathionylation and S-nitrosylation, and that these modifications regulate the chaperone and isomerase activities of PDI, it is likely that an interplay between cytoplasmic and ER redox environment govern the role of PDI in ER stress pathways [8, [53] [54] [55] . The importance of PDI post-translational modifications and their role in ER-stress mediated apoptosis will be discussed in more detail in following sections.
ER stress, PDI and disease Aging, genetic mutations, and environmental stressors may collectively and/ or independently lead to pathologically chronic ER stress and the accumulation of misfolded proteins. Diseases that are a direct result of this protein aggregation are collectively known as 'conformational' or 'folding diseases' [56] . These include atherosclerosis, ischemia, liver and heart disease, diabetes, inflammation and neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and bipolar disorders. ER stress signaling is also associated with the pathology in cancer (Table 1) .
Neurodegenerative diseases
While neurodegenerative diseases are linked with aging and/or have an underlying genetic cause, disease pathogenesis and cell cytotoxicity have been directly associated with an accumulation misfolded, aggregated proteins that form plaques [57, 58] . In
Alzheimer's disease patients, the formation of senile plaques, composed of fibrillar β-amyloid (Aβ), is associated with disease progression. In vitro, the addition of high concentrations of Aβ to mature neurons results in dendritic and axonal retraction followed by neuronal death [59] . In Parkinson's disease patients,
there is an accumulation of α-synuclein in plaques referred to as Lewy Bodies. In vitro models showed that α-synuclein accumulation was toxic to cultured dopamine-dependent human cell apoptosis is induced at extreme thresholds of DNA damage.
The concept of PDI as a pleiotropic apoptotic regulator is further supported by a recent study examining apoptotic pathways in a prion disease [7] . contributes to ER-stress-induced apoptotic events in vivo [83] .
PDI also has a protective role in ischemic cardiomyopathy and in the inhibition of apoptosis during post-infarction remodeling. PDI expression is upregulated in hypoxia-treated myocardial capillary endothelial cells in viable peri-infarct and infarct regions of mouse hearts. Increased PDI expression was correlated with protection against endothelial cell apoptosis as well as in cellular migration, adhesion, and tubular formation.
siRNA-mediated PDI inhibition negates these effects while induced PDI expression confers additional protection against hypoxia-induced apoptosis [84, 85] . While this study did not evaluate subcellular localization of PDI, cell-surface PDI may act as a reductase on the disulfide bond of cell surface proteins or interact with integrins to mediate endothelial cell adhesion and migration [86] . Additional discussion of cell-surface PDI in cancers is included in the following section. The PDI-mediated signaling pathways involved in endothelial cell survival and in
angiogenesis have yet to be clearly defined, but may involve the enzymatic rather than chaperone functions of PDI, since pointmutations in PDIs active sites blocked apoptotic protection.
Severino et al, reported the increased expression of Ero1 and
IRE1 in cardiomyocytes following hypoxic stress as well as PDImediated cellular protection from superoxide through increased SOD1 activity [85] . There are indications that systemic disease conditions may impact the redox state of PDI and its importance in protecting cardiomyocytes from apoptosis [87] . In a mouse model of diabetes, diabetic mice exhibited increases in the reduced form of PDI and decreased post-infarction remodeling as compared to healthy animals. The authors suggest that while diabetic animals showed elevated PDI expression, these increased levels of PDI were confounded by redox-mediated inactivation in diabetic hearts.
The type of cell stress or injury impacts which PDI family member might participate in the regulation of apoptosis.
While PDI up-regulation has a protective role in ischemic cardiomyopathy, hyperoxia-induced down-regulation of ERP57
in neonatal rat lungs and in cultured endothelial cells conferred similar cellular protection. Furthermore, siRNA-mediated ERP57 knockdown inhibited caspase-3 activation and further protected against hyperoxia-induced apoptosis, while ERP57 overexpression exacerbated hyperoxia-or tunicamycin-induced apoptosis and augmented caspase-3 activation, while reducing GRP78 induction [88] .
Cancer
Many cancer-related pathologies are associated with deregulation of ER homeostasis and the induction of ER stress and UPR pathways. ER stress may be the result of protein in PDI-mediated acquisition of tolerance against ischemic stress in glial cells [71] . Indeed, additional investigation into how PDI-family members interact with each other and with other ER and non-ER resident proteins will further elucidate the apoptotic roles of PDI. The up-regulation of chaperone proteins, including GRP78
PDI-mediated apoptotic signaling in other disorders
Diabetes
and GRP94, in the insulin-secreting β-cells of diabetic mouse models further implies a role for additional ER stress-mediated pathways. In Type 2 diabetes models, ectopic overexpression of the molecular chaperones oxygen-regulated protein 150
(ORP-150) and GRP78 in β-cells improves insulin resistance, most likely by improving ER folding capabilities and protecting cells from ER stress-induced apoptosis [76, 77] . However, PDI overexpression induced the opposite effect; resulting in elevated levels of misfolded pro-insulin and a reduction in glucosestimulated insulin secretion and additional ER stress induction.
Such data suggest that the regulation of PDI isomerase and associated chaperone activities may be essential in maintaining β-cell function and viability, whereas PDI overexpression may be lethal.
Cardiovascular Disease
A number of recent studies indicate that ER stress and the UPR are chronically activated in atherosclerotic cells [78] . IRE1α/JNK mediated XBP-1s and CHOP expression [81] . The pro-apoptotic and pro-atherogenic role of prolonged ER stress is exemplified in studies with CHOP -/-mice where knockout animals exhibit a reduction in atherosclerotic plaque necrosis and apoptosis [82] . PDI overexpression counteracts ER stress homeostasis [107] . The cell-surface redox environment may have a pleiotropic impact on PDI-mediated apoptotic pathways, acting directly at the cell membrane as well as intracellularly.
Indeed, human cancer cells treated with redox-modulating agents that modify cell surface thiols show increases in the S-glutathionylation of PDI (PDI-SSG) which leads to inhibition of PDI activity and the induction of UPR-mediated cell death [8, 107] .
Recently, S-glutathionylation of the tumor necrosis factor (TNF)
receptor family member, Fas (CD95, Apo-1), was found to be Therapeutic application of PDI inhibitors in the treatment of cancers that are closely associated with poor prognosis and therapy resistance have shown promise in a number of studies, including those using melanoma, glioblastoma, breast cancer and ovarian cell lines/xenograft models [92, 94, 97, 108] .
PDI knockdown in melanoma and ovarian cell models inhibits xenograft formation and tumor growth and induces cellular apoptosis, in response to ER inducing agents and as a solo treatment, respectively [92, 94] . However, therapeutic application of PDI inhibition may be confounded by studies that suggests that the UPR of different tumor cell lines differentially respond to various UPR stimuli and by differential regulation of ER chaperones. PDI induction was induced following tunicamycin but not ritonavir treatment in sarcoma cell lines [109] . Furthermore, in a single study, siRNA-mediated PDI knockdown induced varying degrees of cytoxicity in human breast cancer, neuroblastoma, and cervical cancer cell lines [108] . (Par-4) [101] . Bcl-2 proteins may have a role in increasing ER permeability and facilitating luminal protein translocation during ER-stress induced apoptosis [102] . Interestingly, cytosolic PDI acts as a substrate for caspase-3 and 7, and overexpression of PDI constructs lacking the KDEL ER retention sequence increased cell survival following the induction of apoptotic stimuli in premyeloid HL-60 cells [103] . PDI may also modulate apoptosis through the reversal of iron(III) mediated caspase-3 inhibition through the formation of iron-sulfur complexes at active site thiols [104] .
Cell-surface redox environment defines thiol content, disulfide bond formation and chaperone function. PDI-mediated reduction of β-integrin disulfide bonds mediates cell migration and adhesion, while its redox-sensitive interaction with other surface proteins serves to facilitate viral entry [37, 86, 105, 106] . diazen-1-ium-1,2-diolate (PABA/NO) resulted in elevated intracellular nitric oxide and the activation of UPR-mediated cytototoxic pathways [8, 55, 112] . PABA/NO-induced cytotoxicity is linked to the S-glutathionylation of cysteines within PDI's active site, which blunts activity and leads to activation of the UPR and JNK activated apoptosis [55] . Recent studies suggest that nitrosative/oxidative induced S-glutathionylation of PDI also impacts the chaperone activity. Specifically it was shown that PDI-SSG mediates UPR activation and cell death through abrogation of estrogen receptor α (ERα) stability and signaling in ERα-positive breast cancer cells [54] . In a model of PABA/ NO acquired drug-resistance, HL60 cells were shown to have a constitutively activated UPR, including elevated levels of PDI, blunted cellular differentiation and decreased levels of S-glutathionylation caused by adaptive GSTP down-regulation
